Home > Dermatology > AAD 2018 > Acne management > Restrictive antibiotic use and novel tetracycline

Restrictive antibiotic use and novel tetracycline

Presented By
Dr Leon Kircik, Indiana University School of Medicine, USA
AAD 2018
Restrictive antibiotic use to fight resistance Dr Neal Bhatia critically discussed the use of oral antibiotics for acne vulgaris [10]. The majority of published guidelines and consensus statements support antibiotic use for inflammatory acne to limit proliferation of P. acnes on the skin. Tetracyclines are recommended as “first-line” agents. However, the use and duration of antibiotics should be limited due to antibiotic resistance concerns [11]. As Dr Bhatia pointed out, dermatologists use more oral antibiotics per prescriber than any other medical specialty, with the main indication being acne vulgaris. Dr Bhatia proposed a more critical use of antibiotics. Systemic antibiotics are only recommended in the management of moderate and severe acne and forms of inflammatory acne that are resistant to topical treatments [11]. Monotherapy should be avoided, and use should be always combined with topical therapy (e.g. retinoids or BPO). A current p...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on